Asenapine Patent Expiration
Asenapine is Used for treating adults with schizophrenia by administering asenapine via a transdermal patch. It was first introduced by Hisamitsu Pharmaceutical Co Inc
Asenapine Patents
Given below is the list of patents protecting Asenapine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Secuado | US11813364 | Patch | Sep 22, 2033 | Hisamitsu |
| Secuado | US10022445 | Patch | Jul 25, 2033 | Hisamitsu |
| Secuado | US10583121 | Patch | Jul 25, 2033 | Hisamitsu |
| Secuado | US10814002 | Patch and method for producing the same | Jul 25, 2033 | Hisamitsu |
| Secuado | US11123305 | Patch | Jul 25, 2033 | Hisamitsu |
| Secuado | US9687474 | Patch | Jul 25, 2033 | Hisamitsu |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Asenapine's patents.
Latest Legal Activities on Asenapine's Patents
Given below is the list recent legal activities going on the following patents of Asenapine.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 10 Apr, 2024 | US10814002 |
| Recordation of Patent Grant Mailed Critical | 14 Nov, 2023 | US11813364 |
| Recordation of Patent eGrant | 14 Nov, 2023 | US11813364 |
| Email Notification Critical | 14 Nov, 2023 | US11813364 |
| Patent Issue Date Used in PTA Calculation Critical | 14 Nov, 2023 | US11813364 |
| Mail Patent eGrant Notification | 14 Nov, 2023 | US11813364 |
| Patent eGrant Notification | 14 Nov, 2023 | US11813364 |
| Email Notification Critical | 27 Oct, 2023 | US11813364 |
| Issue Notification Mailed Critical | 25 Oct, 2023 | US11813364 |
| Dispatch to FDC | 11 Oct, 2023 | US11813364 |
Asenapine's Family Patents
